skip to main content

News Archive

Date: 12/03/2015
Researchers at the University of Michigan have identified a potential new approach to fertility preservation for young cancer patients that addresses concerns about beginning cancer treatment immediately and the possibility of reintroducing cancer cells during the fertility preservation process.
Date: 12/02/2015
When researchers looked at different areas within an individual rectal cancer sample, they found cases in which each area contained different genetic mutations. The findings could have significant implications for treatment recommendations.
Date: 12/01/2015
The University of Michigan Comprehensive Cancer Center has appointed Bhramar Mukherjee, Ph.D., as associate director for population science research.
Date: 11/30/2015
Can any cancer cell form another tumor, or is it only select cancer stem cells that give rise to new cancer cells? The answer, a new study finds, is both.
Date: 11/20/2015
Combinations of a significant number of non-toxic chemicals, many of which can be found in plants and foods, may offer a chance to stop untreatable cancers and prevent disease relapse.
Date: 11/12/2015
Kura Oncology Inc., a clinical stage biopharmaceutical company that develops therapies for cancer patients, is now trading on the NASDAQ after an initial public offering.
Date: 11/10/2015
Patients being treated for breast cancer at the University of Michigan Comprehensive Cancer Center now have a new way to help manage the overload of information and reminders that comes with cancer diagnosis, surgery, chemotherapy or radiation treatment.
Date: 11/03/2015
When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don’t have the weapons to kill the cancer.
Date: 10/27/2015
A new study suggests a potential new way to block one of the most common cancer-causing genes, without causing severe side effects.
Date: 10/26/2015
A new study from the University of Michigan Comprehensive Cancer Center reveals molecular changes within a tumor that are preventing immunotherapy drugs from killing off the cancer. It explains why not all patients respond to immunotherapy treatments.